Cargando…
Reduced USP39 expression inhibits malignant proliferation of medullary thyroid carcinoma in vitro
BACKGROUND: Medullary thyroid carcinoma (MTC) constitutes approximately 5 % of all thyroid cancers and carries a worse prognosis than other differentiated thyroid cancers. Targeted therapies are being investigated for systemic treatment of MTC. Ubiquitin-specific peptidase 39 (USP39) functions in pr...
Autores principales: | An, Yong, Yang, Shuwen, Guo, Kai, Ma, Ben, Wang, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549085/ https://www.ncbi.nlm.nih.gov/pubmed/26303214 http://dx.doi.org/10.1186/s12957-015-0669-4 |
Ejemplares similares
-
The Deubiquitinase USP39 Promotes Esophageal Squamous Cell Carcinoma Malignancy as a Splicing Factor
por: Zhu, Xiaolin, et al.
Publicado: (2022) -
Silencing of zinc finger protein 703 inhibits medullary thyroid carcinoma cell proliferation in vitro and in vivo
por: Yang, Xiaolin, et al.
Publicado: (2020) -
Thyroid: Medullary Carcinoma
por: Somnay, Yash R., et al.
Publicado: (2013) -
Malignant melanoma arising in melanin-producing medullary thyroid carcinoma
por: Hirokawa, Mitsuyoshi, et al.
Publicado: (2016) -
USP39 promotes malignant proliferation and angiogenesis of renal cell carcinoma by inhibiting VEGF-A(165b) alternative splicing via regulating SRSF1 and SRPK1
por: Pan, Xiu-wu, et al.
Publicado: (2021)